Community SDoH Alert!

Ivermectin prophylactic study from India- Dr John Campbell -May 6, 2021

  • Alert date July 2, 2021

    CLICK HERE TO OPEN RELATED DOCUMENT

    Covid 19 Related Resource





    Contact: ALL WHO ARE IMMUNE SUPPRESSED, PLEASE CONTINUE TO MASK UP- WASH YOUR HANDS – SANITIZE – SOCIAL DISTANCE -BOTH INSIDE AND OUTSIDE!!

    Ivermectin in India, Prophylactic role of ivermectin in SARS-CoV-2 infection among healthcare workers.

    Background

    Healthcare workers (HCWs) are vulnerable to getting infected withSARS-CoV-2.

    Preventing HCWs from getting infected is a priority to maintain healthcare services.

    The therapeutic and preventive role of ivermectin in COVID-19 is being investigated.

    Based on promising results of in vitro studies of oral ivermectin, this study to look at prophylactic role of oral ivermectin.

    Methods

    Prospective cohort study was conducted at AIIMS Bhubaneswar.

    Two-doses of oral ivermectin, 300 μg/kg at a gap of 72 hours.

    Primary outcome, COVID-19 infection in the month following.

    Of 3892 employees, 3532 (90.8%) participated in the study.

    Conclusion and relevance

    Two-doses of oral ivermectin (300 μg/kg given 72 hours apart) as chemoprophylaxis among HCWs

    reduces the risk of COVID-19 infection by 83% in the following month.

    Safe, effective, and low-cost chemoprophylaxis have relevance in the containment of pandemic
    alongside vaccine.

Use the share buttons below to share alert with your community
If you are on a phone use the GREEN SMS button to directly send a text

show translator

AmharicEnglishSomali

COPYRIGHT © 2019 SISTERS IN COMMON